نتایج جستجو برای: citalopram hydrobromide

تعداد نتایج: 3768  

Journal: :Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent 2011
Carlo Carandang Rekha Jabbal Angela Macbride Dean Elbe

OBJECTIVE To review the basic pharmacology and published literature regarding escitalopram and citalopram in child and adolescent depression. METHODS A LITERATURE REVIEW WAS CONDUCTED USING THE SEARCH TERMS: 'escitalopram', 'citalopram', 'depression', 'randomized controlled trial', 'open label trial' and limits set to: Human trials, English Language and All Child (Age 0-18). Additional articl...

Journal: :Biological psychiatry 2000
S M Stahl

BACKGROUND Previous comparative studies of the selective serotonin reuptake inhibitors (SSRIs) have rarely included a placebo control group and have rarely demonstrated significant between-group differences. The study reported on here was a placebo-controlled comparison of the antidepressant effects of two SSRIs, citalopram and sertraline. METHODS Three hundred twenty-three patients with DSM-...

Journal: :The Journal of pharmacology and experimental therapeutics 1998
S G Evans N Butkow C Stilwell M Berk N Kirchmann I Havlik

Citalopram, is an extremely potent inhibitor of neuronal serotonin reuptake. It is structurally unrelated to other antidepressants, but it contains the chemical features associated with reversal of drug resistance and exhibits minimal cardiotoxic side effects and fewer of the anticholinergic and adrenolytic side effects associated with other psychotropic agents. Sensitivity tests to citalopram ...

Journal: :Journal of analytical toxicology 2009
Björn Carlsson Anita Holmgren Johan Ahlner Finn Bengtsson

Citalopram is marketed as a racemate (50:50) mixture of the S(+)-enantiomer and R(-)-enantiomer and the active S(+)-enantiomer (escitalopram) that possess inhibitory effects. Citalopram was introduced in Sweden in 1992 and is the most frequently used antidepressant to date in Sweden. In 2002, escitalopram was introduced onto the Swedish market for treatment of depression and anxiety disorders. ...

Journal: :The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2011
Gwenn S Smith Clifford I Workman Elisse Kramer Carol R Hermann Rachel Ginsberg Yilong Ma Vijay Dhawan Thomas Chaly David Eidelberg

OBJECTIVES Given the challenges in the clinical management of geriatric depression, research over the past decade has focused on developing early neurobiological markers of antidepressant treatment response. This study tested the hypothesis that lower baseline glucose metabolism and greater acute cerebral metabolic responses to a single, intravenous (IV) dose of the selective serotonin reuptake...

Journal: :Physiological research 2002
J Hamplová-Peichlová J Krůsek I Paclt J Slavícek V Lisá F Vyskocil

Selective serotonine reuptake inhibitors (SSRI) are believed to be less dangerous in the treatment of depressive disorder in comparison with tricyclic antidepressants (TCA) due to their relative lack of cardiotoxicity. Thus, we investigated the effect of citalopram (SSRI) on membrane electrophysiology in rat cardiomyocytes in tissue culture. The results were compared with those from amitriptyli...

Journal: :international journal of pediatrics 0
z pourmoghaddas child growth and development research center, isfahan university of medical sciences, isfahan, iran. h saneian associate professor of pediatric gastroenterology, isfahan university of medical sciences, isfahan, iran.

introduction: limited data are available on the effectiveness of antidepressants in the treatment of functional gastrointestinal disorders in children. we evaluated the effectiveness of citalopram in the treatment of childhood functional abdominal pain (fap).   material and methods: children with fap (n=115, aged 6-18 years) received either citalopram 20 mg/day or placebo for 4 weeks. treatment...

Journal: :JAMA 2014
Anton P Porsteinsson Lea T Drye Bruce G Pollock D P Devanand Constantine Frangakis Zahinoor Ismail Christopher Marano Curtis L Meinert Jacobo E Mintzer Cynthia A Munro Gregory Pelton Peter V Rabins Paul B Rosenberg Lon S Schneider David M Shade Daniel Weintraub Jerome Yesavage Constantine G Lyketsos

IMPORTANCE Agitation is common, persistent, and associated with adverse consequences for patients with Alzheimer disease. Pharmacological treatment options, including antipsychotics are not satisfactory. OBJECTIVE The primary objective was to evaluate the efficacy of citalopram for agitation in patients with Alzheimer disease. Key secondary objectives examined effects of citalopram on functio...

H Saneian Z Pourmoghaddas

Introduction: Limited data are available on the effectiveness of antidepressants in the treatment of functional gastrointestinal disorders in children. We evaluated the effectiveness of citalopram in the treatment of childhood functional abdominal pain (FAP).   Material and Methods: Children with FAP (n=115, aged 6-18 years) received either citalopram 20 mg/day or placebo for 4 weeks. Tre...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید